Shock Wave Therapy On Cervical Pain Following Neck Dissection Surgery
Keywords
Abstract
Description
The occurrences of morbidity of the neck after cancer therapy were considerable and consisted of neck pain, loss of sensation, and decreased range of motion. Extracorporeal shock wave therapy (ESWT) is one of the treatment options used for patients with myofascial pain syndrome through elimination of ischemia and modulation of vasoneuroactive substance (two major causes of trigger pathophysiology) and mechanical transduction as a cellular response to external stimulation. the aim of this study was to investigate efficacy of extracorporeal shock wave therapy (ESWT) on cervical myofascial pain following neck dissection surgery.
Dates
| Last Verified: | 01/31/2020 |
| First Submitted: | 02/10/2020 |
| Estimated Enrollment Submitted: | 02/11/2020 |
| First Posted: | 02/16/2020 |
| Last Update Submitted: | 02/11/2020 |
| Last Update Posted: | 02/16/2020 |
| Actual Study Start Date: | 11/02/2018 |
| Estimated Primary Completion Date: | 11/19/2019 |
| Estimated Study Completion Date: | 12/02/2019 |
Condition or disease
Intervention/treatment
Device: ESWT Group
Drug: control group
Phase
Arm Groups
| Arm | Intervention/treatment |
|---|---|
| Experimental: ESWT Group received ESWT once a week for 4 weeks (0.25 ml/mm2, 1000 shocks) plus topical none steroidal anti-inflammatory drug (NSAID; 3 times /day for 4 weeks). | Device: ESWT Group Extracorporeal Shock Wave Therapy (ESWT) has been introduced efficiently for more than twenty years as a treatment modality in orthopedic and musculoskeletal disorders. ESWT has mechanical and cellular impacts on tissues regeneration and pain management through cavitation bubbles, acoustic micro streaming, and hyper-vascularity that can directly affect tissue calcifications, and modulate cell activity. |
| Experimental: control group received only topical NSAID. | Drug: control group participants received 1% topical diclofenac gel on the tender points 3 times /day for 4 weeks. |
Eligibility Criteria
| Ages Eligible for Study | 35 Years To 35 Years |
| Sexes Eligible for Study | All |
| Accepts Healthy Volunteers | Yes |
| Criteria | Inclusion Criteria: 1. Previous unilateral modified radical neck dissection. 2. Patients with myofascial pain of upper trapezius for at least 3 months. 3. Patients with palpable intramuscular taut band. 4. Restriction in cervical ROM of lateral flexion and rotation. 5. Provocation of the clinical symptoms by compression of the active trigger point Exclusion Criteria: 1. Patient who received medication or other therapies for MPS within the previous 2 months. 2. Patients with pacemaker, pregnancy 3. Open wound at the treatment area. 4. Cervical myelopathy or radiculopathy, cervical spine fracture or spondylolisthesis. 5. Rheumatoid arthritis. 6. Coagulopathy. 7. Epilepsy or any psychological disorder. |
Outcome
Primary Outcome Measures
1. Visual analogue scale [before treatment]
2. Visual analogue scale [2 weeks of treatment]
3. Visual analogue scale [after 4 weeks of treatment]
Secondary Outcome Measures
1. Cervical range of motion assessment [before treatment]
2. Cervical range of motion assessment [2 weeks of treatment]
3. Cervical range of motion assessment [after 4 weeks of treatment]
